Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00576030
Other study ID # EA4/061/06
Secondary ID EA4/061/06
Status Terminated
Phase N/A
First received December 14, 2007
Last updated July 2, 2010
Start date January 2007
Est. completion date October 2008

Study information

Verified date August 2009
Source Charite University, Berlin, Germany
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

More than 80% of the population in the USA consume coffee each day. However there not many studies on change of heart rate variability and placebo effects after consumption of coffee.

In our study we aim to test the following hypotheses:

1. Habitual caffeinated espresso coffee drinkers show an increase in blood pressure, heart rate variability and parasympathetic activity (high frequency band) of the heart.

2. Non-habitual caffeinated espresso coffee drinkers show an increase of blood pressure. The heart rate variability and the parasympathetic activity of the heart will decrease.

3. Caffeinated or decaffeinated espresso induces comparable changes in habitual or non-habitual coffee drinkers.


Recruitment information / eligibility

Status Terminated
Enrollment 77
Est. completion date October 2008
Est. primary completion date October 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- 18- 50 years old, healthy

Exclusion Criteria:

- Medication, obese(BMI > 30)

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Basic Science


Related Conditions & MeSH terms

  • Influence of Espresso on Heart Rate Variability

Intervention

Other:
hab cof with water
habitual coffee drinker provided with water
hab cof with dec espresso
habitual coffee drinkers given decaffeinated espresso
hab cof with caf espresso
habitual coffee drinkers given caffeinated espresso
non-hab cof with water
non-habitual coffee drinkers given water
non-hab cof with dec espresso
non-habitual coffee drinkers given decaffeinated espresso
non-hab cof with caf espresso
non-habitual coffee drinkers given caffeinated espresso

Locations

Country Name City State
Germany Department of Psychosomatic Medicine and Psychotherapy, Charité University Berlin

Sponsors (1)

Lead Sponsor Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Heart rate variability 70 minutes No
Secondary blood pressure 70 min. No